BFS
WST icon

Bare Financial Services’s West Pharmaceutical WST Stock Holding History

Bare Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Hold
5
– – ﹤0.01% 1160
2026
Q1 		$1.25K Buy
5
+2
+67% +$498 ﹤0.01% 1155
2025
Q4 		$825 Hold
3
– – ﹤0.01% 1197
2025
Q3 		$787 Sell
3
-5
-63% -$1.22K ﹤0.01% 1087
2025
Q2 		$1.75K Buy
8
+2
+33% +$428 ﹤0.01% 768
2025
Q1 		$1.34K Buy
+6
New +$1.65K ﹤0.01% 453

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bare Financial Services's WST Position: Q2 2026 in Review

Bare Financial Services held its West Pharmaceutical (WST) position steady in Q2 2026 at 5 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Bare Financial Services first reported a position in WST in Q1 2025 and has held it in 6 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bare Financial Services held 5 shares of West Pharmaceutical worth $1.79K as of Q2 2026.
  • Bare Financial Services left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1160 holding.
  • Bare Financial Services first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.